BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

698 related articles for article (PubMed ID: 28844973)

  • 1. In-vitro in-vivo correlation (IVIVC) in nanomedicine: Is protein corona the missing link?
    Jain P; Pawar RS; Pandey RS; Madan J; Pawar S; Lakshmi PK; Sudheesh MS
    Biotechnol Adv; 2017 Nov; 35(7):889-904. PubMed ID: 28844973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How protein coronas determine the fate of engineered nanoparticles in biological environment.
    Capjak I; Goreta SŠ; Jurašin DD; Vrček IV
    Arh Hig Rada Toksikol; 2017 Dec; 68(4):245-253. PubMed ID: 29337683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
    Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
    Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotoxicology: advances and pitfalls in research methodology.
    Azhdarzadeh M; Saei AA; Sharifi S; Hajipour MJ; Alkilany AM; Sharifzadeh M; Ramazani F; Laurent S; Mashaghi A; Mahmoudi M
    Nanomedicine (Lond); 2015; 10(18):2931-52. PubMed ID: 26370561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Situ Characterization of Protein Adsorption onto Nanoparticles by Fluorescence Correlation Spectroscopy.
    Shang L; Nienhaus GU
    Acc Chem Res; 2017 Feb; 50(2):387-395. PubMed ID: 28145686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro-in vivo correlation in nanocarriers: From protein corona to therapeutic implications.
    Agnihotri TG; Alexander A; Agrawal M; Dubey SK; Jain A
    J Control Release; 2023 Feb; 354():794-809. PubMed ID: 36709923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research progress and application opportunities of nanoparticle-protein corona complexes.
    Huang W; Xiao G; Zhang Y; Min W
    Biomed Pharmacother; 2021 Jul; 139():111541. PubMed ID: 33848776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of protein corona on the biological behavior of targeting nanomedicines.
    Farshbaf M; Valizadeh H; Panahi Y; Fatahi Y; Chen M; Zarebkohan A; Gao H
    Int J Pharm; 2022 Feb; 614():121458. PubMed ID: 35017025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Nano-Bio Interactions of Nanomedicines: Understanding the Biochemical Driving Forces and Redox Reactions.
    Wang Y; Cai R; Chen C
    Acc Chem Res; 2019 Jun; 52(6):1507-1518. PubMed ID: 31149804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploiting the novel properties of protein coronas: emerging applications in nanomedicine.
    Hamad-Schifferli K
    Nanomedicine (Lond); 2015 May; 10(10):1663-74. PubMed ID: 26008198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration-dependent protein adsorption at the nano-bio interfaces of polymeric nanoparticles and serum proteins.
    Zhang TX; Zhu GY; Lu BY; Zhang CL; Peng Q
    Nanomedicine (Lond); 2017 Nov; 12(22):2757-2769. PubMed ID: 29017387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction between nanoparticles-protein corona complex and cells and its toxic effect on cells.
    Liu N; Tang M; Ding J
    Chemosphere; 2020 Apr; 245():125624. PubMed ID: 31864050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How eluents define proteomic fingerprinting of protein corona on nanoparticles.
    Qiu L; Zhang Y; Wei G; Wang C; Zhu Y; Yang T; Chu Z; Gao P; Cheng G; Ma A; Kwan Wong Y; Zhang J; Xu C; Wang J; Tang H
    J Colloid Interface Sci; 2023 Oct; 648():497-510. PubMed ID: 37307606
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Singh N; Marets C; Boudon J; Millot N; Saviot L; Maurizi L
    Nanoscale Adv; 2021 Mar; 3(5):1209-1229. PubMed ID: 36132858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein corona, understanding the nanoparticle-protein interactions and future perspectives: A critical review.
    Kopac T
    Int J Biol Macromol; 2021 Feb; 169():290-301. PubMed ID: 33340622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of dynamic flow environment on nanoparticle-protein corona: From protein patterns to uptake in cancer cells.
    Palchetti S; Pozzi D; Capriotti AL; Barbera G; Chiozzi RZ; Digiacomo L; Peruzzi G; Caracciolo G; Laganà A
    Colloids Surf B Biointerfaces; 2017 May; 153():263-271. PubMed ID: 28273493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Crown and the Scepter: Roles of the Protein Corona in Nanomedicine.
    Cai R; Chen C
    Adv Mater; 2019 Nov; 31(45):e1805740. PubMed ID: 30589115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein corona variation in nanoparticles revisited: A dynamic grouping strategy.
    Rezaei G; Daghighi SM; Haririan I; Yousefi I; Raoufi M; Rezaee F; Dinarvand R
    Colloids Surf B Biointerfaces; 2019 Jul; 179():505-516. PubMed ID: 31009853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic Understanding of Protein Corona Formation around Nanoparticles: Old Puzzles and New Insights.
    Nienhaus K; Nienhaus GU
    Small; 2023 Jul; 19(28):e2301663. PubMed ID: 37010040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein corona and nanoparticles: how can we investigate on?
    Pederzoli F; Tosi G; Vandelli MA; Belletti D; Forni F; Ruozi B
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Nov; 9(6):. PubMed ID: 28296346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.